From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.  They have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations.  Their team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.

Investment Management

OrbiMed

OrbiMed's headquarters in New York, NY, United States

Managing Partners

Carl L. Gordon

Sven H. Borho

David Wang

Matthew S. Rizzo

Steven D. Wang

Mona Ashiya

Erez Chimovits

Peter Thompson

David Bonita

C. Scotland Stevens

Girish Bakhru

Trevor M. Polischuk

Rishi Gupta

Geoffrey C. Hsu

Description

People (31)

Carl L. Gordon

David Bonita

Trevor M. Polischuk

David Wang

Diyong Xu

Jia Sun

Alexis Megibow

Trey Block

Jessica Zhang

Andrew Kanarek

Zack Mager

Kipyegon Kitur

Savannah Loomis

Stephen Pearn

Daniel Rhee

Melissa Dorogoff

Joseph Frezza

Brendan Weber

Evans Meireles

Christina Petrungaro

Judy Liu

Scott Winer

Tyler Dunham

Cason Kim

Kamran Elahi

Brian Glowatz

Jason Kahn

Corey Schrader

Lauren Ralph

Manjot Bhuller

Nate Yee

Jobs